Actavis in Chinese pharmaceuticals deal

Actavis, the international generic pharmaceuticals company, has signed an agreement with the Zhejiang Chiral Medicine Chemicals Company in Hangzhou, China. Actavis will take a 90% share in the Chinese company which specialises in research, development and production of active pharmaceutical ingredients (APIs). The acquisition is part of Actavis’ strategy to gain ... Read More...